Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinoma.

CONCLUSIONS: Circulating cell-free miR-375 proved as a surrogate marker for tumor burden in MCC without restriction to polyomavirus positivity, it thus appears to be useful for therapy monitoring and the follow-up of MCC patients.
PMID: 30061360 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - July 30, 2018 Category: Cancer & Oncology Authors: Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, Odum N, Woetmann A, Tothill RW, Hicks RJ, Sand M, Schrama D, Schadendorf D, Ugurel S, Becker JC Tags: Clin Cancer Res Source Type: research